COGT
Price
$4.26
Change
+$0.24 (+5.97%)
Updated
Apr 11 closing price
Capitalization
485M
31 days until earnings call
FOLD
Price
$6.48
Change
-$0.03 (-0.46%)
Updated
Apr 11 closing price
Capitalization
1.99B
25 days until earnings call
Ad is loading...

COGT vs FOLD

Header iconCOGT vs FOLD Comparison
Open Charts COGT vs FOLDBanner chart's image
Cogent Biosciences
Price$4.26
Change+$0.24 (+5.97%)
Volume$1.22M
Capitalization485M
Amicus Therapeutics
Price$6.48
Change-$0.03 (-0.46%)
Volume$3.81M
Capitalization1.99B
COGT vs FOLD Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. FOLD commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and FOLD is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 12, 2025
Stock price -- (COGT: $4.26 vs. FOLD: $6.48)
Brand notoriety: COGT and FOLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 89% vs. FOLD: 127%
Market capitalization -- COGT: $485M vs. FOLD: $1.99B
COGT [@Biotechnology] is valued at $485M. FOLD’s [@Biotechnology] market capitalization is $1.99B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.66B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileFOLD’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • FOLD’s FA Score: 0 green, 5 red.
According to our system of comparison, both COGT and FOLD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 3 TA indicator(s) are bullish while FOLD’s TA Score has 4 bullish TA indicator(s).

  • COGT’s TA Score: 3 bullish, 4 bearish.
  • FOLD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, FOLD is a better buy in the short-term than COGT.

Price Growth

COGT (@Biotechnology) experienced а -10.69% price change this week, while FOLD (@Biotechnology) price change was -13.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.15%. For the same industry, the average monthly price growth was -16.20%, and the average quarterly price growth was -17.21%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

FOLD is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+0.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FOLD($1.99B) has a higher market cap than COGT($485M). FOLD YTD gains are higher at: -31.210 vs. COGT (-45.385). FOLD has higher annual earnings (EBITDA): 29.4M vs. COGT (-271.59M). COGT has more cash in the bank: 287M vs. FOLD (250M). COGT has less debt than FOLD: COGT (17.5M) vs FOLD (444M). FOLD has higher revenues than COGT: FOLD (528M) vs COGT (0).
COGTFOLDCOGT / FOLD
Capitalization485M1.99B24%
EBITDA-271.59M29.4M-924%
Gain YTD-45.385-31.210145%
P/E RatioN/AN/A-
Revenue0528M-
Total Cash287M250M115%
Total Debt17.5M444M4%
FUNDAMENTALS RATINGS
COGT vs FOLD: Fundamental Ratings
COGT
FOLD
OUTLOOK RATING
1..100
5055
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
76100
SMR RATING
1..100
9693
PRICE GROWTH RATING
1..100
9690
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FOLD's Valuation (70) in the Biotechnology industry is in the same range as COGT (81) in the Miscellaneous industry. This means that FOLD’s stock grew similarly to COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (76) in the Miscellaneous industry is in the same range as FOLD (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to FOLD’s over the last 12 months.

FOLD's SMR Rating (93) in the Biotechnology industry is in the same range as COGT (96) in the Miscellaneous industry. This means that FOLD’s stock grew similarly to COGT’s over the last 12 months.

FOLD's Price Growth Rating (90) in the Biotechnology industry is in the same range as COGT (96) in the Miscellaneous industry. This means that FOLD’s stock grew similarly to COGT’s over the last 12 months.

FOLD's P/E Growth Rating (100) in the Biotechnology industry is in the same range as COGT (100) in the Miscellaneous industry. This means that FOLD’s stock grew similarly to COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTFOLD
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
70%
Declines
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 2 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSSEX10.24N/A
N/A
Fidelity SAI Sustainable Intl Eq
JFEAX14.51N/A
N/A
JPMorgan Developed International Value A
MFEHX157.34N/A
N/A
MFS Growth R3
FFECX12.50N/A
N/A
Nuveen Dividend Value C
HRMVX23.25N/A
N/A
Harbor Mid Cap Value Admin

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+5.97%
SPHDF - COGT
63%
Loosely correlated
N/A
ETNB - COGT
50%
Loosely correlated
+10.71%
XNCR - COGT
47%
Loosely correlated
+7.83%
ENGN - COGT
47%
Loosely correlated
N/A
CRNX - COGT
46%
Loosely correlated
+8.42%
More

FOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if FOLD jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
-0.46%
VCYT - FOLD
43%
Loosely correlated
+5.12%
ROIV - FOLD
41%
Loosely correlated
+2.18%
AXON - FOLD
39%
Loosely correlated
+3.03%
DNLI - FOLD
37%
Loosely correlated
+1.60%
COGT - FOLD
36%
Loosely correlated
+5.97%
More